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 Peptides serve a myriad of functions in the human body.  They are the backbone 
of complex structures as well the primary vessel for biological catalysis.  The human 
body is a complex equilibrium of chemical components held in check by the activity and 
regulation of the infinite number of these peptides catalysts, or enzymes, present at any 
time.  Because this chemical balance is so sensitive, many degenerative diseases are 
caused by the inaction or faulty action of existing enzymes.  Attempting to repair or assist 
enzymes is an extremely difficult task. This is because peptides are so complex; 
containing hundreds or thousands of amino acids in a unique and controlled sequence to 
create the perfect structure for which to catalyze biological reactions.  However, each 
enzyme typically has one site in which it performs its catalytic role.  This active site is the 
focal point of the entire molecule and any subtle change to it can have dramatic effects on 
its shape and therefore its biological action.  This extremely important site is often very 
small, especially in comparison to the entire peptide.  Instead of attempting to alter the 
complex biological proteins, it is often more effective to create a model of the active site.  
This model is created with a similar shape and composition of the enzyme active site and 
can mimic its role.  Using this model, we can see the effects of subtle changes and assess 
the usefulness of synthetically created molecules in relation to the natural enzyme; this is 
the basis for peptidomimetics.  This approach allows for the simplest view of the enzyme 
in order to better understand its function and different ways to alter it.   
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative 
disorders, affecting nearly 15 million people worldwide and because of its severe 
symptoms and lack of proven treatment it causes significant stress on the patient’s family 
as well as the patient1.  The exact pathenogensis of the disease is unclear, what is 
common in patients with Alzheimer’s disease, as well as Huntington’s and Parkinson’s, is 
the buildup of plaques within the brain tissue as the disease progresses.  Analysis of these 
plaques has shown no significant relationship between their formation and the 
degenerative effects of the disease2.  There is also a growing amount of evidence that 
suggests that these plaques may be the result of the body’s natural defense attempting to 
fight the disease3.  This supports the emerging hypothesis that the true toxic agent in AD 
is the soluble oligomeric form of the Amyloid-β (Aβ) proteins that constitute the plaque 
buildup in patients.  The Aβ proteins found in these plaques are products linked to the 
cleavage of Amyloid Precursor Protein (APP).   
There is experimental evidence that Amyloid β -binding alcohol dehydrogenase 
(ABAD) is an intracellular target of Aβ and this interaction may play a role in the onset 
of AD.  Under normal cellular conditions, ABAD plays a protective role in healthy 
neurons.  However, in the presence of elevated levels of Aβ, its role appears to be 
reversed as the occurrence of ABAD- Aβ complexes are enhanced in affected areas of an 
AD patient’s brain4.  The X-ray structure of the complex shows distortions at the active 
site and a secondary site, labeled LD loop5.  There appears to be a unique insertion point 
for Aβ at this LD loop.  These results suggest that the ABAD- Aβ complex can be a 
stepping stone in the understanding of the chain of events that takes place in AD. 
The first step in understanding the relationship between ABAD and Aβ is to 
understand the way in which they bind and how the complex functions.  To do this, a 
minimal model of the LD loop of ABAD and the fragment of Aβ that is implicated in 
binding will be created synthetically.  To screen these samples, one of the pieces will be 
immobilized by attaching it covalently to a micro plate.  The other piece, and easily any 
interesting derivatives, can then be screened and viewed if attached to a fluorophore or 
another similar labeling molecule.  A spacer can be used to aid in the screening process 
by attaching it to the micro plate and the immobilized molecule; this allows the molecule 
to be more flexible and easily augmentable during the screening process. 
 
                          
 Figure 1.  Visual Representation of the modeling style, the same structure can be 
employed using the labeling model in place of the micro plate pore. 
 
 In a related experiment, the catalytic activity of a small tetra peptide will be 
examined and compared to its naturally occurring counterpart.  Metalloporteins are 
enzymes that catalyze a wide range of chemical reactions with relevance to medicinal 
chemistry as well as alternative energy sources.  In the human body, enzymes often use 
the aid of copper(II) or Iron(II) to catalyze oxidation reactions.  Evidence of this is seen 
in the active site of enzymes such as laccases, catecholases, and monooxygenases.   In 
each case, the most common metal coordinating amino acid is histidine.   It has been 
demonstrated that a small functional model of these complex enzymes can still have 
catalytic activity6.  Their results suggest that a simple tetra peptide with residues His-His-
Gly-His can be used as a starting point in experimenting with the catalytic activity of 
these small peptides.  While their experiment only encompassed biological oxidation, the 
same principle catalyst may be used to assist oxidation of other substrates.  As noted 
before, a subtle change in the model’s composition can have dramatic effects on its 
catalytic ability.  Towards this end, artificial residues containing 1, 2, 4-triazoles as 
histidine replacements were synthesized and incorporated into the tetra peptide sequences 
in hopes that this substitution can diversify the possible substrates of the catalytic peptide.  
The resulting peptide analogs will then be screened for their ability to complex copper 















Tetra Ethylene Glycol (TEG) Spacers 
 
 Synthesis of the TEG spacers 
was done using classic liquid phase 
synthesis starting with tetra ethylene 
glycol itself.  They were synthesized in 
a way that there can be variable 
functional groups on one end of the 
molecule but retain the carboxylic acid 
end on the other to facilitate 
attachment of the peptide sequences.   
  Beginning with TEG, molecule 
1 is created using ethyl diazoacetate.  
Molecule 2 is then synthesized by 
oxidizing the alcohol.  From molecule 
1, the alcohol can be converted to a 
Tosyl group to yield molecule 3.  The 
Tosyl group can then be displaced by a 
cyanide group, a trityl group, and an 
azide to yield molecules 4, 5, and 6 
respectively.  Molecule 6 can then be 
reduced to yield an amine (molecule 
7), or saponified to replenish the carboxylic acid necessary for peptide formation 
(molecule 8).  The amino group of molecule 7 can then be converted to either a nitrile or 
a biotin group yielding molecules 10 and 9 respectively.  Saponification of molecules 9 
and 10 yielded molecules 12 and 13.  Molecule 8 could also be reduced to an amine 
(molecule 11) and then converted to a nitrile (Molecule 13) as well.   
 The major products are highlighted with boxes.  These all possess the carboxylic 
end and an opposing functional group that facilitates attachment to many micro plate 
resins or other functional pieces.  Molecule 5 was a focus point for the current micro 
plates in use because its trityl group reacts with maleimide freely to form a covalent 
disulfide linkage.  The biotin and azide groups form a similar covalent interaction with 
other micro plates. 











Tetra Peptide Synthesis 
 
 The three triazole analogues were created modeling the structure of histadine. 
 
                          
                             Figure 3.  From left to right, Histadine and the three variable 1,2,4 Triazole analogues 
 
These analogues were each created using a one step synthesis following the general 
reaction scheme of  
 
              
  
The three starting materials were glycine, beta alanine, and gamma-amino butyric acid 
and the reactant used in this experiment was an azene compound created separately and 
purified as a hydrochloride salt of the above compound.  In each case, three equivalents 
of triethyl amine were used and the reaction proceeded for two days at 80° Celsius, being 
monitored by thin layer chromatography (TLC) (Ninhydrin Stain).  After sufficient 
conversion is noted by TLC, the reaction mixture is filtered and washed with hexane and 
ethyl ether.  Converting the terminal amine of these compounds into the triazole creates a 
different structure than the natural occurring histidine which has its ring on a side chain 
and retains a terminal amino group.  This conversion provides a much easier route of 
synthesis than attempting to retain both a terminal amino group and a side chain triazole 
and it brings the functionality of a triazole into the molecule in order to assess the effect 
of its replacement. 
 The four residue peptides were created by solid phase peptide synthesis using 
Fmoc-amino acid (Fmoc = 9-fluorenylmethoxycarbonly) methodology.  Rink Amide 
resin was used as the solid support.  Starting with the solid support, each residue was 
coupled with the aid of HBTU, HOBt, and N,N-diisopropylethlamine in NMP.  At each 
stage the residue’s protecting group was removed using piperdine then the coupling 
solution was added and allowed to couple for 1-3 hours.  The residues were added 
sequentially following the general order of Histidine-Glycine-Histidine-X, where X is 
one of the three triazoles or histidine in the control.  The simplest route was to synthesize 




TEG Linker Synthesis 
 
 The linkers synthesized from TEG were all purified to the point of being one spot 
by TLC and verified by DART mass spectrometry.  Purification at each step was 
completed by silica gel chromatography.  Specific emphasis was placed on the creation of 
molecule 5 for the current micro plates and also molecule 8.  Molecule 8 has potential in 
being used not only as a linker for micro plates, but also for covalent attachment to other 
molecules following the general “Click” reaction.  In this reaction, an azide, such as the 
spacer molecule contains, attaches itself to an alkyne or nitrile under aqueous conditions 
to form a ring.  This attachment has many applications, and can be used for the 
attachments of peptide models as well as other small molecules that may have activity 
with the Aβ peptide.  It can also be used for attachment of molecules that may aid or 
inhibit catalytic activity.   
Upon completion they were incorporated into various peptide sequences that had 
possible activity with piece Aβ implicated in activity.  This was often done with the aid 
of a peptide synthesizer; in this case the spacer of choice was dissolved in NMP just as 
any amino acid residue and added via the same coupling sequence via the carboxylic acid 
end.  This attachment was verified by MALDI mass spectrometry and HPLC. 
 
Tetra Peptide Synthesis 
 
 Synthesis of the proposed triazole analogues proved to be difficult.  The reaction 
conditions listed initially were used and produced satisfactory results by TLC and by 
DART mass spectrometry.  However, the presence of an unknown contaminant persisted 
through the initial reaction conditions as well as further recrystallization.  While it did not 
appear in the DART spectrometry, the contaminated was identified to behave similarly to 
triethylamine by GCMS and NMR.  While normally, it would not persist through 
methanol crystallization, it may have done so in the form of an ionic salt with the triazole 
product.  After separation of the two proved to be extremely difficult, the triazole 
monomers were created again using no triethyl amine and were refluxed in toluene for 
three days at 90º Celsius.  After this period, the reaction mixture was evaporated and 
washed with ethanol; this ethanol was then collected and evaporated to yield a yellow oil.  
This process again yielded the product, yet it remained impure showing the masses of a 
larger byproduct likely from incomplete reaction with the azine.   
 The peptides created in this experiment were done without the difficulty noted in 
the monomer synthesis.  Using the above techniques the His-Gly-His peptide as well as 
the His-Gly-His-His control peptide was created and verifed by MALDI mass 
spectrometry and HPLC.  Taking small amounts of the His-Gly-His peptide, the triazole-
triethyl amine salt compounds were added in an attempt to couple.  This process did not 
appear to work as the resulting product was one peptide by HPLC but the corresponding 






 The linkers synthesized for attachment of molecules to current micro plates 
proved to work well for their role.  They were easily incorporated at the end of peptide 
sequences and worked as an attachment device for small molecules.  This will aid in the 
further testing of not only Aβ peptide but a wide range of chemicals that may be useful in 
understanding and altering the function of peptides related to Alzheimer’s disease.  The 
triazole monomer synthetic strategy must be adjusted if the testing of their catalytic 
activity is to be done.  Because of the nature of contamination, it was very difficult to 
purify the molecules and it wasn’t possible to make any observation of activity.  Another 
realm of future research would be to abandon the simple modification of the terminal 
amine of an amino acid monomer and attempt to covalently modify the side chain of an 
amino acid.  This would allow for the triazole to be incorporated at any location in the 
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